Literature DB >> 28409357

Diffusion-weighted MRI to assess response to chemoradiotherapy in rectal cancer: main interpretation pitfalls and their use for teaching.

Doenja M J Lambregts1, Miriam M van Heeswijk2,3,4,5, Andrea Delli Pizzi6, Saskia G C van Elderen7, Luisa Andrade8, Nicky H G M Peters9, Peter A M Kint10, Margreet Osinga-de Jong9, Shandra Bipat11, Rik Ooms12, Max J Lahaye2, Monique Maas2, Geerard L Beets5,13, Frans C H Bakers3, Regina G H Beets-Tan2,5.   

Abstract

OBJECTIVES: To establish the most common image interpretation pitfalls for non-expert readers using diffusion-weighted imaging (DWI) to assess response to chemoradiotherapy in patients with rectal cancer and to explore the use of these pitfalls in an expert teaching setting.
METHODS: Two independent non-expert readers (R1 and R2) scored the restaging DW MRI scans (b1,000 DWI, in conjunction with ADC maps and T2-W MRI scans for anatomical reference) in 100 patients for the likelihood of a complete response versus residual tumour using a five-point confidence score. The readers received expert feedback and the final response outcome for each case. The supervising expert documented any potential interpretation errors/pitfalls discussed for each case to identify the most common pitfalls.
RESULTS: The most common pitfalls were the interpretation of low signal on the ADC map, small susceptibility artefacts, T2 shine-through effects, suboptimal sequence angulation and collapsed rectal wall. Diagnostic performance (area under the ROC curve) was 0.78 (R1) and 0.77 (R2) in the first 50 patients and 0.85 (R1) and 0.85 (R2) in the final 50 patients.
CONCLUSIONS: Five main image interpretation pitfalls were identified and used for teaching and feedback. Both readers achieved a good diagnostic performance with an AUC of 0.85. KEY POINTS: • Fibrosis appears hypointense on an ADC map and should not be mistaken for tumour. • Susceptibility artefacts on rectal DWI are an important potential pitfall. • T2 shine-through on rectal DWI is an important potential pitfall. • These pitfalls are useful to teach non-experts how to interpret rectal DWI.

Entities:  

Keywords:  Chemoradiotherapy; Diagnosis; Diffusion magnetic resonance imaging; Magnetic resonance imaging; Rectal neoplasms

Mesh:

Year:  2017        PMID: 28409357     DOI: 10.1007/s00330-017-4830-z

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  22 in total

1.  Learning curve in the detection of ovarian and deep endometriosis by using Magnetic Resonance: comparison with surgical results.

Authors:  Luca Saba; Stefano Guerriero; Rosa Sulis; Monica Pilloni; Silvia Ajossa; Gianbenedetto Melis; Giorgio Mallarini
Journal:  Eur J Radiol       Date:  2010-02-19       Impact factor: 3.528

2.  Locally advanced rectal cancer: is diffusion weighted MRI helpful for the identification of complete responders (ypT0N0) after neoadjuvant chemoradiation therapy?

Authors:  S Sassen; M de Booij; M Sosef; R Berendsen; G Lammering; R Clarijs; M Bakker; R Beets-Tan; F Warmerdam; R Vliegen
Journal:  Eur Radiol       Date:  2013-07-06       Impact factor: 5.315

3.  Rectal cancer: assessment of complete response to preoperative combined radiation therapy with chemotherapy--conventional MR volumetry versus diffusion-weighted MR imaging.

Authors:  Luís Curvo-Semedo; Doenja M J Lambregts; Monique Maas; Thomas Thywissen; Rana T Mehsen; Guido Lammering; Geerard L Beets; Filipe Caseiro-Alves; Regina G H Beets-Tan
Journal:  Radiology       Date:  2011-06-14       Impact factor: 11.105

Review 4.  Patients who undergo preoperative chemoradiotherapy for locally advanced rectal cancer restaged by using diagnostic MR imaging: a systematic review and meta-analysis.

Authors:  Marije P van der Paardt; Marjolein B Zagers; Regina G H Beets-Tan; Jaap Stoker; Shandra Bipat
Journal:  Radiology       Date:  2013-06-25       Impact factor: 11.105

5.  Value of diffusion-weighted imaging in the detection of viable tumour after neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer: comparison with T2 weighted and PET/CT imaging.

Authors:  I Song; S H Kim; S J Lee; J Y Choi; M J Kim; H Rhim
Journal:  Br J Radiol       Date:  2011-02-22       Impact factor: 3.039

6.  Transanal endoscopic versus total mesorectal laparoscopic resections of T2-N0 low rectal cancers after neoadjuvant treatment: a prospective randomized trial with a 3-years minimum follow-up period.

Authors:  E Lezoche; M Guerrieri; A M Paganini; G D'Ambrosio; M Baldarelli; G Lezoche; F Feliciotti; A De Sanctis
Journal:  Surg Endosc       Date:  2005-05-04       Impact factor: 4.584

7.  Magnetic resonance imaging for the clinical management of rectal cancer patients: recommendations from the 2012 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting.

Authors:  Regina G H Beets-Tan; Doenja M J Lambregts; Monique Maas; Shandra Bipat; Brunella Barbaro; Filipe Caseiro-Alves; Luís Curvo-Semedo; Helen M Fenlon; Marc J Gollub; Sofia Gourtsoyianni; Steve Halligan; Christine Hoeffel; Seung Ho Kim; Andrea Laghi; Andrea Maier; Søren R Rafaelsen; Jaap Stoker; Stuart A Taylor; Michael R Torkzad; Lennart Blomqvist
Journal:  Eur Radiol       Date:  2013-06-07       Impact factor: 5.315

8.  Long-term Outcome of an Organ Preservation Program After Neoadjuvant Treatment for Rectal Cancer.

Authors:  Milou H Martens; Monique Maas; Luc A Heijnen; Doenja M J Lambregts; Jeroen W A Leijtens; Laurents P S Stassen; Stephanie O Breukink; Christiaan Hoff; Eric J Belgers; Jarno Melenhorst; Rob Jansen; Jeroen Buijsen; Ton G M Hoofwijk; Regina G H Beets-Tan; Geerard L Beets
Journal:  J Natl Cancer Inst       Date:  2016-08-10       Impact factor: 13.506

9.  Can radiographers be trained to triage CT colonography for extracolonic findings?

Authors:  Thierry N Boellaard; C Yung Nio; Patrick M M Bossuyt; Shandra Bipat; Jaap Stoker
Journal:  Eur Radiol       Date:  2012-07-03       Impact factor: 5.315

10.  MRI and diffusion-weighted MRI to diagnose a local tumour regrowth during long-term follow-up of rectal cancer patients treated with organ preservation after chemoradiotherapy.

Authors:  Doenja M J Lambregts; Max J Lahaye; Luc A Heijnen; Milou H Martens; Monique Maas; Geerard L Beets; Regina G H Beets-Tan
Journal:  Eur Radiol       Date:  2015-10-30       Impact factor: 5.315

View more
  16 in total

Review 1.  Diffusion-weighted imaging in rectal cancer: current applications and future perspectives.

Authors:  Niels W Schurink; Doenja M J Lambregts; Regina G H Beets-Tan
Journal:  Br J Radiol       Date:  2019-03-05       Impact factor: 3.039

2.  The split scar sign as an indicator of sustained complete response after neoadjuvant therapy in rectal cancer.

Authors:  Inês Santiago; Maria Barata; Nuno Figueiredo; Oriol Parés; Vanessa Henriques; António Galzerano; Carlos Carvalho; Celso Matos; Richard J Heald
Journal:  Eur Radiol       Date:  2019-07-26       Impact factor: 5.315

3.  Predictive role of diffusion-weighted MRI in the assessment of response to total neoadjuvant therapy in locally advanced rectal cancer.

Authors:  Franco Iafrate; Fabio Ciccarelli; Giorgio Maria Masci; Damiano Grasso; Francesco Marruzzo; Francesca De Felice; Vincenzo Tombolini; Giancarlo D'Ambrosio; Fabio Massimo Magliocca; Enrico Cortesi; Carlo Catalano
Journal:  Eur Radiol       Date:  2022-08-18       Impact factor: 7.034

4.  Prediction of tumor budding in patients with rectal adenocarcinoma using b-value threshold map.

Authors:  Fangying Chen; Shaoting Zhang; Xiaolu Ma; Yukun Chen; Zhen Wang; Yan Zhu; Chenguang Bai; Caixia Fu; Robert Grimm; Chengwei Shao; Jianping Lu; Fu Shen; Luguang Chen
Journal:  Eur Radiol       Date:  2022-08-23       Impact factor: 7.034

5.  Assessing Rectal Cancer Treatment Response Using Coregistered Endorectal Photoacoustic and US Imaging Paired with Deep Learning.

Authors:  Xiandong Leng; K M Shihab Uddin; William Chapman; Hongbo Luo; Sitai Kou; Eghbal Amidi; Guang Yang; Deyali Chatterjee; Anup Shetty; Steve Hunt; Matthew Mutch; Quing Zhu
Journal:  Radiology       Date:  2021-03-23       Impact factor: 11.105

Review 6.  The importance of MRI for rectal cancer evaluation.

Authors:  Maria Clara Fernandes; Marc J Gollub; Gina Brown
Journal:  Surg Oncol       Date:  2022-03-18       Impact factor: 2.388

Review 7.  Rectal cancer MRI: protocols, signs and future perspectives radiologists should consider in everyday clinical practice.

Authors:  Andrea Delli Pizzi; Raffaella Basilico; Roberta Cianci; Barbara Seccia; Mauro Timpani; Alessandra Tavoletta; Daniele Caposiena; Barbara Faricelli; Daniela Gabrielli; Massimo Caulo
Journal:  Insights Imaging       Date:  2018-04-19

8.  Cross-Sectional Study on MRI Restaging After Chemoradiotherapy and Interval to Surgery in Rectal Cancer: Influence on Short- and Long-Term Outcomes.

Authors:  Robin Detering; Wernard A A Borstlap; Lisa Broeders; Linda Hermus; Corrie A M Marijnen; Regina G H Beets-Tan; Willem A Bemelman; Henderik L van Westreenen; Pieter J Tanis
Journal:  Ann Surg Oncol       Date:  2018-12-13       Impact factor: 5.344

9.  MRI Assessment of Complete Response to Preoperative Chemoradiation Therapy for Rectal Cancer: 2020 Guide for Practice from the Korean Society of Abdominal Radiology.

Authors:  Seong Ho Park; Seung Hyun Cho; Sang Hyun Choi; Jong Keon Jang; Min Ju Kim; Seung Ho Kim; Joon Seok Lim; Sung Kyoung Moon; Ji Hoon Park; Nieun Seo
Journal:  Korean J Radiol       Date:  2020-07       Impact factor: 3.500

10.  Predicting Treatment Response of Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Using Amide Proton Transfer MRI Combined With Diffusion-Weighted Imaging.

Authors:  Weicui Chen; Liting Mao; Ling Li; Qiurong Wei; Shaowei Hu; Yongsong Ye; Jieping Feng; Bo Liu; Xian Liu
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.